Levocetirizin Al

Levocetirizine dihydrochloride, the active ingredient in Levocetirizin Al, is a second‑generation antihistamine presented as an oral dosage form for oral use. It treats allergic rhinitis and chronic idiopathic urticaria in adults and children. GNH USA supplies Levocetirizin Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizin Al is a selective H1‑receptor antagonist used to manage allergic conditions. - Allergic rhinitis: relieves nasal congestion, sneezing, itching and rhinorrhoea. - Chronic idiopathic urticaria: reduces the frequency and severity of hives and associated itching. - Seasonal allergic rhinitis: controls episodic nasal and ocular symptoms triggered by pollen or other seasonal allergens.

Adverse reactions may occur with levocetirizine use.

Common Side Effects: - Drowsiness: mild to moderate sedation, especially at treatment initiation. - Headache: transient, often resolves without intervention. - Dry mouth: reduced salivation causing mild discomfort. - Fatigue: general feeling of tiredness. - Altered taste: temporary metallic or bitter sensation. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue requiring urgent care. - Severe rash or Stevens‑Johnson syndrome: extensive skin involvement. - Anaphylaxis: rapid onset of systemic allergic reaction. - Thrombocytopenia: unusually low platelet count. - Hepatic injury: elevated liver enzymes or jaundice.

Before prescribing Levocetirizin Al, consider the following safety measures. - Renal function assessment: dose may need adjustment in impaired clearance. - Elderly patients: monitor for increased sedation or confusion. - Driving and machinery: avoid operating until individual response is known. - Hypersensitivity history: discontinue if rash or swelling develops. - Concomitant CNS depressants: use with caution due to additive drowsiness. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levocetirizin Al can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other H1 antihistamines: additive antihistaminic effect may increase sedation. - Alcohol or sedative agents: heightened drowsiness and impaired psychomotor performance.

Moderate Interactions (Monitor Closely): - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise plasma levocetirizine levels. - CYP1A2 inducers (e.g., theophylline, smoking): may reduce drug exposure. - Anticholinergic drugs: combined dry‑mouth effect may be more pronounced.